American Society of Hirudotherapy

Conditions Atlas

174 medical conditions where hirudotherapy has been applied — from FDA-cleared microsurgical flap salvage to Tier C investigational uses. Every entry tier-classified, evidence-graded, and linked to primary literature.

Last Updated: May 27, 2026ASH Editorial · based on the books
Conditions registry — mixed tiers: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Catalog of indications: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

174

Total conditions

3

Tier A FDA-cleared

7

Tier B RCT-supported

164

Tier C investigational

cardiovascular

4 conditions

dermatological

36 conditions

Livedo Reticularis

C · Investigational

Investigational use for primary livedo reticularis; no clinical study was identified. Secondary causes (lupus, APLAS) require rheumatology referral.

Lipodermatosclerosis

C · Investigational

Investigational use for chronic lipodermatosclerosis; no study in this condition was identified, only small series in venous ulcer and varicose disease.

Insulin Injection Lipohypertrophy

C · Investigational

Investigational use for insulin injection-related lipohypertrophy nodules; no clinical study of leech therapy for them was identified.

Androgenic Alopecia

C · Investigational

Investigational use for androgenic alopecia; the only clinical report is a single-patient Ayurvedic case study, with no controlled trial.

Rosacea (Erythematotelangiectatic)

C · Investigational

Investigational use for erythematotelangiectatic rosacea; no clinical study of leech therapy was identified.

Plaque Psoriasis (Localized)

C · Investigational

Investigational adjunct, not a primary treatment; a few small, mostly uncontrolled studies report lower PASI scores.

Atopic Eczema (Localized Refractory)

C · Investigational

Investigational use for localized refractory eczema; evidence is limited to a few small studies without placebo or standard-care controls.

Keloid and Hypertrophic Scarring

C · Investigational

Investigational use for keloid and hypertrophic scars; evidence is limited to one small uncontrolled series and two conflicting single-patient reports.

Chronic Recurrent Cellulitis

C · Investigational

Investigational use for chronic recurrent (non-acute) cellulitis with underlying lymphedema or venous insufficiency.

Hidradenitis Suppurativa (Hurley Stage I-II)

C · Investigational

Not recommended: the only published report of leech therapy in hidradenitis suppurativa describes a harmful outcome.

Severe Inflammatory Acne Vulgaris

C · Investigational

Highly investigational use for severe nodulocystic acne refractory to isotretinoin; small Ayurvedic studies only, none in refractory disease, and scarring risk concerns.

Hypertrophic Scars

C · Investigational

Investigational adjunct for hypertrophic scars (within the original wound), distinct from keloid; evidence is one small uncontrolled Russian series.

Cutaneous Lichen Planus (Localized)

C · Investigational

Investigational use for localized cutaneous lichen planus refractory to topical corticosteroid; very limited case-report evidence.

Small Localized Subcutaneous Lipoma

C · Investigational

Highly investigational use for small subcutaneous lipoma (<3 cm) with cosmetic concern; surgical excision remains standard; very limited data.

Plantar Warts (Verruca Plantaris, Refractory)

C · Investigational

Highly investigational use for refractory plantar warts (HPV-mediated) after cryotherapy and salicylic acid failure; very limited anecdotal evidence.

Small Localized Skin Abscess (Post-Drainage)

C · Investigational

Investigational adjunct after drainage of small localized skin abscess; not for undrained abscesses; evidence limited to reports, mostly in related infections.

Vitiligo (Investigational)

C · Investigational

Highly investigational adjunct for limited stable vitiligo; case reports only; topical calcineurin inhibitors, narrow-band UVB, and ruxolitinib cream remain primary.

Alopecia Areata (Investigational Adjunct)

C · Investigational

Investigational adjunct for stable patchy alopecia areata; case reports only; intralesional corticosteroids and JAK inhibitors (baricitinib, ritlecitinib) remain primary.

Melasma (Investigational Adjunct)

C · Investigational

Highly investigational adjunct for refractory melasma; uncontrolled reports only; sun protection, hydroquinone, tretinoin, tranexamic acid, and chemical peels remain primary.

Post-Inflammatory Hyperpigmentation (Investigational)

C · Investigational

Highly investigational adjunct for refractory PIH; no clinical study found; sun protection, topical hypopigmenting agents, and chemical peels remain primary.

Lichen Sclerosus (Investigational Adjunct)

C · Investigational

Highly investigational adjunct for refractory lichen sclerosus; one small uncontrolled series (vulvar), no RCT; clobetasol remains standard of care.

Granuloma Annulare (Investigational Adjunct)

C · Investigational

Highly investigational adjunct for localized granuloma annulare; no clinical study found; many lesions resolve spontaneously within 1-2 years.

Localized Scleroderma / Morphea (Investigational Adjunct)

C · Investigational

Highly investigational adjunct for stable plaque morphea; no RCT evidence; UVA1 phototherapy and methotrexate remain primary for active disease.

Cutis Marmorata Telangiectatica Congenita (Investigational)

C · Investigational

Highly investigational; supportive care and monitoring of associated anomalies remain primary; no clinical report of leech therapy for CMTC was identified.

Chronic Radiation Dermatitis (Investigational)

C · Investigational

Highly investigational adjunct for chronic radiation dermatitis after oncology completion; no clinical report of leech therapy was identified; standard skin care and dermatology referral remain primary.

Shingles (Acute Herpes Zoster)

C · Investigational

No controlled study of leech therapy for acute shingles exists; antiviral treatment started early is standard care, and leeches must never be placed on or near the rash.

Nail Psoriasis (Investigational Adjunct)

C · Investigational

Investigational adjunct for nail psoriasis; topical corticosteroids, intralesional steroid, and (for severe disease) systemic biologics remain evidence-based.

Prurigo Nodularis (Investigational Adjunct)

C · Investigational

Investigational adjunct for refractory prurigo nodularis; potent topical/intralesional steroids, gabapentinoids, and dupilumab (FDA-approved 2022) remain evidence-based.

Chronic Pruritus of Unknown Origin (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic pruritus of unknown origin after systemic workup; antihistamines, gabapentinoids, and (for select cases) systemic immunomodulators remain evidence-based.

Behcet Disease Orogenital Mucocutaneous Manifestations (Investigational Adjunct)

C · Investigational

Investigational adjunct for cutaneous manifestations of Behcet disease; colchicine, apremilast, azathioprine, TNF inhibitors, and rheumatology supervision remain evidence-based.

Chronic Recurrent Chilblains (Pernio, Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic recurrent chilblains; cold avoidance, smoking cessation, calcium channel blockers (nifedipine), and topical corticosteroids remain evidence-based.

Chronic Idiopathic Urticaria (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic spontaneous urticaria refractory to high-dose H1 antihistamines; omalizumab, cyclosporine, and step-up guideline-directed therapy remain evidence-based.

Recurrent Erythema Nodosum (Investigational Adjunct)

C · Investigational

Investigational adjunct for recurrent idiopathic erythema nodosum; identification and treatment of underlying cause, NSAIDs, potassium iodide, and (refractory) colchicine remain evidence-based.

Hailey-Hailey Disease (Benign Familial Pemphigus, Investigational Adjunct)

C · Investigational

Investigational adjunct for refractory Hailey-Hailey disease; topical corticosteroids, topical antibiotics, topical calcineurin inhibitors, oral antibiotics, and (refractory) botulinum toxin or surgical interventions remain evidence-based.

Lichen Simplex Chronicus (Investigational Adjunct)

C · Investigational

Investigational adjunct for lichen simplex chronicus; breaking the itch-scratch cycle with potent topical corticosteroids, occlusion, topical calcineurin inhibitors, and treatment of underlying pruritus etiology remain evidence-based.

Necrobiosis Lipoidica (Investigational Adjunct)

C · Investigational

Investigational adjunct for stable non-ulcerated necrobiosis lipoidica; no clinical leech study was identified; topical corticosteroids remain first-line.

ent

15 conditions

Chronic Rhinosinusitis

B · RCT-supported

Investigational use for chronic rhinosinusitis; no clinical study of leech therapy for this condition was identified, and the rationale is mechanistic.

Subjective Tinnitus

C · Investigational

Investigational for tinnitus; small non-randomized studies, mostly Russian, report less ear noise, and no study using the Tinnitus Handicap Inventory was identified.

Ménière's Disease (Adjunctive)

C · Investigational

Investigational adjunct for Ménière's disease with no clinical study identified; standard management (diet, betahistine, intratympanic therapy) remains primary.

Pulsatile Tinnitus (Vascular-Origin Subtype)

C · Investigational

Investigational use for pulsatile vascular-origin tinnitus distinct from subjective tinnitus; no clinical study of leech therapy for this subtype was identified.

Peripheral Vertigo (BPPV-Refractory / Vestibular Neuritis Recovery)

C · Investigational

Investigational adjunct for peripheral vertigo persisting after Epley maneuvers or during prolonged vestibular neuritis recovery; no study specific to these conditions was identified.

Chronic Tonsillitis (Investigational Cervical Adjunct)

C · Investigational

Highly investigational cervical adjunct for chronic tonsillitis; no clinical study found; tonsillectomy and antibiotics remain primary; cervical leech placement carries carotid-proximity risk.

Recurrent Otitis Media in Adults (Investigational)

C · Investigational

Highly investigational adjunct for adult recurrent otitis media; no condition-specific study found; antibiotics and ENT evaluation remain primary.

Vasomotor Rhinitis (Investigational)

C · Investigational

Investigational adjunct for nonallergic vasomotor rhinitis; one uncontrolled Russian series only; intranasal ipratropium and antihistamine remain primary.

Chronic Laryngitis (Investigational Cervical Adjunct)

C · Investigational

Highly investigational cervical adjunct for chronic laryngitis; no clinical study found; ENT evaluation for underlying causes remains primary.

Chronic Glossitis (Investigational Adjunct)

C · Investigational

Highly investigational adjunct for chronic glossitis; no study in glossitis found; treating nutritional, infectious or allergic causes remains primary.

Sensorineural Hearing Loss (chronic) and Sudden Hearing Loss

C · Investigational

No randomized trial was found; a few small reports without described randomization or blinding mention less ear noise and some hearing gain in chronic loss. Sudden hearing loss is an emergency: urgent ENT care comes first, and leeches must never delay it.

Chronic Otitis Externa (Investigational Adjunct)

C · Investigational

Investigational adjunct for refractory chronic otitis externa; topical antimicrobials, aural toilet, and predisposing-factor management remain evidence-based.

Sicca Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for sicca (dry eye and dry mouth) symptoms; ophthalmologic lubricants, salivary stimulants (pilocarpine, cevimeline), and rheumatology workup remain evidence-based.

Burning Mouth Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for primary burning mouth syndrome; clonazepam (topical or systemic), alpha-lipoic acid, low-dose tricyclics, and cognitive behavioral therapy remain evidence-based.

Chronic Eustachian Tube Dysfunction (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic Eustachian tube dysfunction; nasal corticosteroids, antihistamines for allergic etiology, Valsalva maneuvers, and (refractory) balloon Eustachian tuboplasty remain evidence-based.

gastrointestinal

9 conditions

Hemorrhoids (Grade II-III, Symptomatic)

C · Investigational

Investigational use for symptomatic relief of grade II-III internal/external hemorrhoidal disease; does not address anatomic prolapse.

Chronic Anal Fissure (>8 Weeks)

C · Investigational

Investigational idea for chronic anal fissure refractory to medical therapy; no clinical study identified; sphincterotomy remains the gold standard.

Non-Alcoholic Fatty Liver Disease (Investigational Adjunct)

C · Investigational

Investigational adjunct in NAFLD/MASLD; no human clinical study identified; weight loss, dietary modification, and resmetirom remain primary.

Hepatic Portal Congestion (Non-Cirrhotic, Investigational)

C · Investigational

Highly investigational adjunct for non-cirrhotic hepatic congestion; uncontrolled Russian series only; cirrhosis and portal hypertension are absolute exclusions.

Chronic Pancreatitis (Investigational Pain Adjunct)

C · Investigational

Highly investigational adjunct for chronic pancreatitis pain refractory to conventional therapy; no clinical study identified; pancreatic enzyme replacement and pain medicine remain primary.

Ulcerative Proctitis (Investigational Adjunct)

C · Investigational

Highly investigational adjunct for distal ulcerative proctitis; no clinical study found; topical 5-ASA and corticosteroids remain primary.

Symptomatic Gilbert Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for symptomatic Gilbert syndrome; reassurance, trigger avoidance (fasting, dehydration), and acknowledgment of benign genetic etiology remain primary; no FDA-approved therapy.

Functional Dyspepsia (Investigational Adjunct)

C · Investigational

Investigational adjunct for functional dyspepsia (Rome IV criteria); H. pylori eradication when positive, proton pump inhibitors, prokinetics, and tricyclic antidepressants remain evidence-based.

Irritable Bowel Syndrome, Pain-Predominant (Investigational Adjunct)

C · Investigational

Investigational adjunct for pain-predominant IBS refractory to dietary and pharmacologic therapy; low-FODMAP diet, antispasmodics, low-dose tricyclic antidepressants, and cognitive behavioral therapy or gut-directed hypnotherapy remain evidence-based.

gynecologic

11 conditions

Lactational Mastitis (Non-Suppurative)

C · Investigational

Investigational adjunctive use proposed for non-suppurative lactational mastitis; no clinical study of leech therapy was identified.

Endometriosis-Related Pelvic Pain

C · Investigational

Investigational adjunctive use for chronic endometriosis-related pelvic pain; very limited evidence. Not a substitute for hormonal or surgical management.

Primary Dysmenorrhea

C · Investigational

Investigational for primary dysmenorrhea; one small randomized trial of leeches plus cupping versus an oral contraceptive pill reported lower pain scores.

Chronic Pelvic Pain Syndrome (Non-Specific)

C · Investigational

Investigational for non-specific chronic pelvic pain; the only clinical report located is an uncontrolled 60-woman series in which leeches were one part of multimodal care.

Premenstrual Syndrome (Investigational)

C · Investigational

Investigational adjunct for moderate PMS refractory to conventional therapy; no clinical study identified; SSRI and combined hormonal contraception remain primary.

Polycystic Ovary Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct in PCOS; no clinical study identified; lifestyle modification, combined hormonal contraception, metformin, and ovulation induction remain primary.

Vulvodynia (Investigational)

C · Investigational

Highly investigational adjunct for chronic vulvodynia refractory to conventional therapy; no clinical study identified; pelvic floor PT, topical therapy, and TCAs remain primary.

Cyclical Mastalgia (Investigational Adjunct)

C · Investigational

Investigational adjunct for severe cyclical mastalgia refractory to conventional therapy; no clinical study identified; reassurance, lifestyle modification, and selective danazol/tamoxifen remain primary.

Pelvic Congestion Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for pelvic congestion syndrome; medical therapy (progestins, GnRH analogs) and ovarian vein embolization remain evidence-based.

Endometrioma (Palliative Investigational Adjunct)

C · Investigational

Palliative investigational adjunct for endometrioma-related chronic pelvic pain in patients declining or unable to undergo surgical/hormonal management.

Adenomyosis (Investigational Palliative Adjunct)

C · Investigational

Investigational palliative adjunct for adenomyosis-related dysmenorrhea and pelvic pain; hormonal therapy (LNG-IUD, dienogest, GnRH antagonists) and (definitively) hysterectomy remain evidence-based.

musculoskeletal

33 conditions

Knee Osteoarthritis

B · RCT-supported

Off-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.

Rheumatoid Arthritis

C · Investigational

No published clinical study of leech therapy in rheumatoid arthritis was identified; early disease-modifying treatment remains the standard, and leeches must never replace or delay it.

Thumb Carpometacarpal (CMC-1) Osteoarthritis

B · RCT-supported

Off-label use with one small RCT (Michalsen 2008, 32 women) in which single-session leech therapy reduced pain and improved hand function more than topical diclofenac for about 2 months.

Lateral Epicondylitis (Tennis Elbow)

B · RCT-supported

Off-label use with one small RCT (Bäcker 2011, n=40) in which a single leech session reduced pain more than topical diclofenac at day 7; the pain difference was no longer significant at day 45.

Plantar Fasciitis

C · Investigational

Investigational use; no clinical study of leech therapy for plantar fasciitis was identified, and the rationale is mechanistic only.

Chronic Low Back Pain (nonspecific)

B · RCT-supported

One small, unblinded randomized trial (Hohmann 2018, n=44): back pain was lower 4 weeks after leech therapy than after exercise therapy; follow-up 8 weeks.

Fibromyalgia

C · Investigational

Investigational use only: no controlled clinical study of leech therapy for fibromyalgia was identified, and it is not a primary treatment.

Acute Gout Flare

C · Investigational

Investigational use for acute monoarticular gout when NSAIDs and colchicine are contraindicated; evidence limited to a few small Ayurvedic pilot studies.

Mid-Substance Achilles Tendinopathy

C · Investigational

Investigational use for chronic mid-substance Achilles tendinopathy; evidence limited to isolated single-patient reports.

Rotator Cuff Tendinopathy

C · Investigational

Investigational use for non-surgical rotator cuff tendinopathy and chronic shoulder impingement; evidence limited to isolated case reports.

Trigger Finger (Stenosing Tenosynovitis)

C · Investigational

Investigational use for stenosing tenosynovitis of the digital flexor pulleys; evidence limited to a single Ayurvedic case report.

Dupuytren's Contracture (Early Stage)

C · Investigational

Investigational use in Dupuytren's disease; evidence limited to one uncontrolled Russian-language report in patients with contracture.

Plantar Fibromatosis (Ledderhose Disease)

C · Investigational

Investigational use for plantar fascia nodules in early Ledderhose disease; no clinical study of leech therapy for this condition was identified.

Adhesive Capsulitis (Frozen Shoulder)

C · Investigational

Investigational adjunct in frozen shoulder; the only clinical reports identified are two single-patient case reports, with no controlled data.

Insertional Achilles Tendinopathy

C · Investigational

Investigational use for insertional Achilles tendinopathy; no clinical study of leech therapy for it was identified.

De Quervain's Tenosynovitis

C · Investigational

Investigational use for stenosing tenosynovitis of the first dorsal extensor compartment; no clinical study of leech therapy for it was identified.

Calcaneal Heel Spur (Symptomatic)

C · Investigational

Investigational use for symptomatic plantar calcaneal spur; distinguished from plantar fasciitis by radiographic spur with localized pain.

Subacromial Bursitis (Chronic)

C · Investigational

Investigational use for chronic subacromial bursitis (not acute septic bursitis); no clinical study of leech therapy was identified.

Costochondritis (Chronic)

C · Investigational

Investigational use for chronic costochondritis after cardiac causes are excluded; no clinical study of leech therapy was identified.

Sacroiliac Joint Dysfunction

C · Investigational

Investigational use for SI joint mechanical pain with positive provocation tests; no clinical study of leech therapy was identified.

Pubic Symphysis Dysfunction (Non-Pregnancy)

C · Investigational

Investigational use for non-pregnancy pubic symphysis dysfunction, including osteitis pubis; no clinical study of leech therapy was identified.

Coccydynia (Chronic)

C · Investigational

Investigational use for chronic coccyx pain after fall, childbirth, or idiopathic onset; no clinical study of leech therapy was identified.

Piriformis Syndrome (Isolated, FAIR-Positive)

C · Investigational

Investigational use for isolated piriformis syndrome (positive FAIR test, lumbar pathology excluded); no clinical study of leech therapy was identified.

Myofascial Pain Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic myofascial trigger-point pain; one small randomized trial (n=66) and Russian clinical series only; dry needling, manual therapy, and exercise remain primary.

Patellar Tendinopathy (Jumper's Knee, Investigational)

C · Investigational

Investigational adjunct for chronic patellar tendinopathy (Blazina stage II-III); eccentric loading and heavy slow resistance training remain primary.

Proximal Hamstring Tendinopathy (Investigational)

C · Investigational

Investigational adjunct for chronic proximal hamstring tendinopathy at ischial origin; eccentric loading and load management remain primary.

Greater Trochanteric Pain Syndrome (Investigational)

C · Investigational

Investigational adjunct for chronic greater trochanteric pain syndrome (gluteal tendinopathy); load management and hip-abductor strengthening remain primary.

Ischial Bursitis (Investigational Adjunct)

C · Investigational

Investigational adjunct for refractory ischial (ischiogluteal) bursitis; activity modification, hamstring loading, and selective injection remain primary.

Hip Osteoarthritis (Investigational Adjunct)

C · Investigational

Investigational adjunct for symptomatic hip osteoarthritis; weight management, exercise, NSAIDs, and arthroplasty for end-stage disease remain evidence-based.

Temporomandibular Joint Disorder (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic temporomandibular joint disorder; conservative care (education, jaw exercises, occlusal splint, NSAIDs) remains first-line; specialty referral for refractory cases.

Chronic Cervical Myofascial Pain (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic cervical myofascial pain; education, exercise therapy, ergonomic correction, and trigger-point therapy remain primary.

Ankylosing Spondylitis Axial Pain (Investigational Adjunct)

C · Investigational

Investigational adjunct for axial pain in ankylosing spondylitis; NSAIDs, biologic DMARDs (TNF and IL-17 inhibitors), and structured exercise remain evidence-based first-line therapy.

Iliotibial Band Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic iliotibial band syndrome refractory to standard physical therapy and load-management; activity modification, eccentric hip strengthening, and corticosteroid injection remain evidence-based.

neurological

31 conditions

Cervical Radiculopathy

C · Investigational

Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.

Lumbar Radiculopathy (Sciatica)

C · Investigational

Investigational use for lumbar radiculopathy; the closest randomized evidence is in chronic low back pain (Hohmann 2018, n=44), not radicular pain.

Migraine

C · Investigational

Investigational use; the only clinical studies found in journal searches are a 7-patient case series and a 26-patient non-randomized pilot (older reports are described in “What the books describe”), and the proposed mechanism is hypothetical.

Tension-Type Headache

C · Investigational

Investigational use for chronic tension-type headache; no study for this headache type was identified, and the proposed mechanism (muscle tension, venous congestion) is untested.

Sciatica (Non-Discogenic / Piriformis)

C · Investigational

Investigational use for non-discogenic sciatica including piriformis syndrome; no controlled trial, only an old unquantified Russian case series.

Bell's Palsy (Acute Idiopathic Facial Paralysis)

C · Investigational

Investigational adjunct in acute idiopathic facial nerve palsy; no controlled trial identified, only uncontrolled series and single-case reports.

Trigeminal Neuralgia (Classical / Idiopathic)

C · Investigational

Investigational use for classical trigeminal neuralgia refractory to first-line carbamazepine; only two single-patient case reports were located in journals (see also “What the books describe”).

Lumbosacral Radiculopathy (Non-Discogenic)

C · Investigational

Investigational use for lumbosacral radicular pain without disc herniation (foraminal stenosis, facet hypertrophy, lateral recess); no study specific to this subtype was identified.

Carpal Tunnel Syndrome (Mild-Moderate)

C · Investigational

Investigational use for mild-to-moderate carpal tunnel syndrome; only one single-patient case report and one randomized-trial protocol without results were identified.

Tarsal Tunnel Syndrome

C · Investigational

Investigational use for posterior tibial nerve entrapment at the medial ankle; no clinical study of leech therapy for it was identified.

Cluster Headache (Episodic)

C · Investigational

Highly investigational use for episodic cluster headache between attack cycles; very limited anecdotal data, not for active attacks.

Cervicogenic Headache

C · Investigational

Investigational adjunct for cervicogenic headache referred from upper cervical (C1-C3) joints; no clinical study in diagnosed cases was identified.

Restless Leg Syndrome (Investigational)

C · Investigational

Investigational adjunct for primary RLS refractory to dopamine agonists; no clinical study was identified; iron status and conventional therapy should be optimized first.

Post-Stroke Hemiplegia (Investigational Adjunct)

C · Investigational

Investigational adjunct to physical/occupational therapy in chronic post-stroke hemiplegia; no RCT support; not for acute stroke care.

Multiple Sclerosis Fatigue (Investigational Adjunct)

C · Investigational

Investigational adjunct for MS-related fatigue; no clinical study was identified; disease-modifying therapy and modafinil/amantadine remain primary.

Parkinson's Disease Rigidity (Investigational Adjunct)

C · Investigational

Investigational adjunct for muscular rigidity in idiopathic Parkinson's disease; no clinical study identified; levodopa and physiotherapy remain primary.

Chronic Fatigue Syndrome / ME (Investigational)

C · Investigational

Investigational adjunct for myalgic encephalomyelitis/chronic fatigue syndrome; no clinical study identified; conventional pacing and symptom management remain primary.

Complex Regional Pain Syndrome (Type I, Investigational)

C · Investigational

Highly investigational adjunct for CRPS Type I; one case report and no controlled study identified; multidisciplinary pain management and physiotherapy remain primary.

Phantom Limb Pain (Investigational)

C · Investigational

Highly investigational adjunct for chronic phantom limb pain; no clinical study identified; mirror therapy and gabapentinoids remain primary.

Spasticity Post-Spinal Cord Injury (Investigational Adjunct)

C · Investigational

Investigational adjunct for muscular spasticity after SCI; no clinical study identified; baclofen (oral or intrathecal) and physiotherapy remain primary.

Vascular Cognitive Impairment (Highly Investigational)

C · Investigational

Highly investigational; no clinical study of leech therapy with cognitive outcomes was identified; vascular risk-factor management (BP, lipids, antiplatelet, lifestyle) remains primary.

Vestibular Migraine (Investigational Adjunct)

C · Investigational

Investigational adjunct for refractory vestibular migraine; migraine prophylaxis (propranolol, topiramate, amitriptyline) and vestibular rehabilitation remain primary.

Idiopathic Intracranial Hypertension (Highly Investigational)

C · Investigational

Highly investigational. Acetazolamide, weight loss, and (for vision-threatening cases) CSF shunting or optic nerve sheath fenestration remain primary; no clinical study of leech therapy for intracranial pressure was identified.

Ramsay Hunt Syndrome (Investigational Adjunct, Convalescent Phase)

C · Investigational

Investigational adjunct for convalescent-phase Ramsay Hunt syndrome residual facial weakness; antiviral plus corticosteroid started within 72 hours of onset remains evidence-based.

Post-Herpetic Neuralgia (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic post-herpetic neuralgia; gabapentinoids, tricyclics, and topical lidocaine/capsaicin remain evidence-based; herpes zoster vaccine prevents new cases.

Diabetic Peripheral Neuropathy (Investigational Adjunct)

C · Investigational

Investigational adjunct for symptomatic diabetic peripheral neuropathy; glycemic control, foot care, and pharmacotherapy (duloxetine, pregabalin, gabapentin) remain evidence-based.

Cubital Tunnel Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for mild cubital tunnel syndrome; elbow extension splinting and ergonomic modification remain first-line; surgical decompression for moderate-severe cases.

Thoracic Outlet Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for neurogenic thoracic outlet syndrome; postural correction and scalene rehabilitation remain first-line; surgical decompression for refractory or vascular subtypes.

Meralgia Paresthetica (Investigational Adjunct)

C · Investigational

Investigational adjunct for meralgia paresthetica; weight loss, loosening of constrictive clothing, and selective nerve block remain first-line.

Medication-Overuse Headache (Investigational Adjunct)

C · Investigational

Investigational adjunct during withdrawal phase of medication-overuse headache; supervised medication discontinuation and preventive therapy initiation remain the foundation.

Cervical Spondylotic Myelopathy Pain (Investigational Adjunct)

C · Investigational

Investigational adjunct for paraspinal pain in mild cervical spondylotic myelopathy; surgical decompression remains evidence-based when myelopathic signs progress; conservative management for mild non-progressive disease.

ophthalmologic

3 conditions

other

5 conditions

surgical reconstruction

3 conditions

urogenital

9 conditions

Peyronie's Disease (Stable Phase)

C · Investigational

Investigational use for stable-phase Peyronie's disease; evidence limited to one uncontrolled Russian series of 29 patients. Standard treatments (verapamil, collagenase, surgery) remain first-line.

Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)

C · Investigational

Investigational for category III CP/CPPS: evidence is limited to a 3-patient case report, an uncontrolled Russian series and a comparison in urogenital infection; multimodal therapy remains standard.

Interstitial Cystitis / Bladder Pain Syndrome (Investigational)

C · Investigational

Highly investigational adjunct for IC/BPS refractory to conventional therapy; no clinical study identified; AUA-guideline stepwise therapy remains primary.

Varicocele (Investigational Adjunct)

C · Investigational

Highly investigational adjunct in symptomatic varicocele; no varicocele-specific clinical study identified; embolization or surgical ligation remain primary for fertility or pain indications.

Chronic Epididymitis (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic epididymitis after infection ruled out; NSAIDs, scrotal support, and selective surgery (epididymectomy) for refractory cases.

Chronic Orchialgia (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic orchialgia (testicular pain) after workup; pharmacotherapy, pelvic-floor physical therapy, and (selectively) microsurgical denervation of the spermatic cord remain evidence-based.

Prostatic Calculi (Investigational Adjunct)

C · Investigational

Investigational adjunct for symptomatic prostatic calculi associated with chronic prostatitis; targeted antibiotics, alpha blockers, and selective transurethral resection remain evidence-based.

Benign Prostatic Hyperplasia (Investigational Adjunct)

C · Investigational

Investigational adjunct for symptomatic benign prostatic hyperplasia; alpha-blockers, 5-alpha-reductase inhibitors, and minimally invasive surgical therapy remain evidence-based.

Chronic Pelvic Floor Myalgia (Investigational Adjunct)

C · Investigational

Investigational adjunct for chronic pelvic floor myalgia; pelvic-floor physical therapy is first-line; biofeedback, trigger-point injection, and (for selected refractory cases) onabotulinumtoxinA remain evidence-based.

vascular

15 conditions

Chronic Venous Insufficiency (CEAP C3-C5)

B · RCT-supported

Off-label adjunct to compression; the journal evidence is one small open-label randomized trial in varicose veins (n=50) and a 20-patient uncontrolled series; the books describe further reports (see “What the books describe” below).

Venous Leg Ulcer

B · RCT-supported

Off-label adjunct to compression therapy; the journal evidence is one 20-patient uncontrolled series in complicated varicose veins plus case reports; the books add an older report on trophic ulcers of unspecified origin (see “What the books describe” below).

Post-Thrombotic Syndrome

C · Investigational

Investigational use; no controlled trial was identified, and the only clinical report is a 1998 conference series of 87 patients without a comparison group.

Varicose Veins (Symptomatic Tributaries)

C · Investigational

Investigational use for symptomatic relief of varicose tributary discomfort and inflammation; does not eliminate underlying venous reflux.

Raynaud's Syndrome (Primary)

C · Investigational

Investigational use for primary Raynaud's phenomenon; the only clinical report is three patients in a 2025 Azerbaijani case series, with no controlled trial.

Primary or Secondary Lymphedema

C · Investigational

Investigational adjunctive use; no clinical study of leech therapy for lymphedema was identified.

Deep Vein Thrombosis (Post-Acute Phase Symptoms)

C · Investigational

Investigational use for residual symptoms in the post-acute phase of DVT (>6 weeks); contraindicated in acute DVT.

Superficial Thrombophlebitis (Saphenous Tributary)

C · Investigational

Investigational use for superficial thrombophlebitis of saphenous tributaries (not DVT); evidence limited to small, mostly Soviet and Russian series.

Erythromelalgia (Investigational)

C · Investigational

Highly investigational use for primary or secondary erythromelalgia (red, hot, painful extremities); no clinical study of leech therapy was identified.

Type 2 Diabetes Microvascular Complications (Investigational)

C · Investigational

Investigational adjunct for microvascular complications of type 2 diabetes; one small randomized trial in neuropathy plus case reports; glycemic control and standard pharmacotherapy remain primary.

Buerger's Disease / Thromboangiitis Obliterans (Investigational Adjunct)

C · Investigational

Investigational adjunct for Buerger's disease; absolute tobacco cessation is the only disease-modifying intervention; iloprost and surgical sympathectomy for selected cases.

Asymptomatic Mild-to-Moderate Carotid Stenosis (Investigational Adjunct)

C · Investigational

Investigational adjunct for asymptomatic mild-to-moderate carotid stenosis; risk-factor management (statin, antiplatelet, blood pressure, smoking cessation, glycemic control) remains evidence-based; symptomatic or high-grade disease requires vascular surgery referral.

Hand-Arm Vibration Syndrome (Investigational Adjunct)

C · Investigational

Investigational adjunct for vascular and neurosensory components of hand-arm vibration syndrome; cessation of vibration exposure, smoking cessation, calcium channel blockers for vascular component, and gabapentinoids for neurosensory pain remain evidence-based.

Early-Stage Lipedema (Investigational Adjunct)

C · Investigational

Investigational adjunct for stage 1 lipedema; no clinical study of leech therapy was identified, and conservative decongestive care remains primary.

Livedoid Vasculopathy (Investigational Adjunct)

C · Investigational

Investigational adjunct for livedoid vasculopathy; no clinical leech study was identified, and anticoagulation and IVIG remain guideline first-line.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.